Potential synergy between tau aggregation inhibitors and tau chaperone modulators.

Potential synergy between tau aggregation inhibitors and tau chaperone modulators.

Item
http://www.wikidata.org/entity/Q38138165
Redox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brain.Synthesis, stereochemical analysis, and derivatization of myricanol provide new probes that promote autophagic tau clearance.Protein homeostasis gene dysregulation in pretangle-bearing nucleus basalis neurons during the progression of Alzheimer's diseaseAzaphilones inhibit tau aggregation and dissolve tau aggregates in vitroTherapeutic Strategies for Restoring Tau Homeostasis.Human iPSC-Derived Neuronal Model of Tau-A152T Frontotemporal Dementia Reveals Tau-Mediated Mechanisms of Neuronal Vulnerability.Stages and conformations of the Tau repeat domain during aggregation and its effect on neuronal toxicityTherapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer's disease.Hsp90 and FKBP51: complex regulators of psychiatric diseases.
P2860

Potential synergy between tau aggregation inhibitors and tau chaperone modulators.

Item
http://www.wikidata.org/entity/Q38138165
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Potential synergy between tau aggregation inhibitors and tau chaperone modulators.
@en
type
label
Potential synergy between tau aggregation inhibitors and tau chaperone modulators.
@en
prefLabel
Potential synergy between tau aggregation inhibitors and tau chaperone modulators.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Potential synergy between tau aggregation inhibitors and tau chaperone modulators
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P6179
P698
P921
P932